Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Lymphoma

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 10 articles: HTML format

Single Articles

November 2022
1. SUNGUC C, Hawkins MM, Winter DL, Dudley IM, et al
   Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
   Br J Cancer. 2022 Nov 1. pii: 10.1038/s41416-022-02016.
   PubMed     Abstract available
   
   
   October 2022
2. BUTLER EN, Zhou CK, Curry M, McMenamin U, et al
   Testosterone therapy and cancer risks among men in the SEER-Medicare linked database.
   Br J Cancer. 2022 Oct 28. pii: 10.1038/s41416-022-02019.
   PubMed     Abstract available
   
   
   August 2022
3. EKBERG S, Crowther M, Harrysson S, Jerkeman M, et al
   Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission.
   Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01931.
   PubMed     Abstract available
   
   
   May 2022
4. NOBLE RA, Thomas H, Zhao Y, Herendi L, et al
   Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma.
   Br J Cancer. 2022 May 26. pii: 10.1038/s41416-022-01848.
   PubMed     Abstract available
   
   
   November 2021
5. AITAMER M, Akil H, Vignoles C, Branchaud M, et al
   CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles.
   Br J Cancer. 2021 Nov 6. pii: 10.1038/s41416-021-01611.
   PubMed     Abstract available
   
   
   October 2021
6. DURAND-PANTEIX S, Monteil J, Sage M, Garot A, et al
   Preclinical study of (212)Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma.
   Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01585.
   PubMed     Abstract available
   
   
   
7. HOUNSOME L, Eyre TA, Ireland R, Hodson A, et al
   Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England.
   Br J Cancer. 2021 Oct 5. pii: 10.1038/s41416-021-01525.
   PubMed     Abstract available
   
   
   August 2021
8. SMITH MJ, Fernandez MAL, Belot A, Quartagno M, et al
   Investigating the inequalities in route to diagnosis amongst patients with diffuse large B-cell or follicular lymphoma in England.
   Br J Cancer. 2021 Aug 13. pii: 10.1038/s41416-021-01523.
   PubMed     Abstract available
   
   
   May 2021
9. CAI J, Tian X, Ma S, Zhong L, et al
   A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
   Br J Cancer. 2021 May 19. pii: 10.1038/s41416-021-01434.
   PubMed     Abstract available
   
   
   December 2020
10. AMERATUNGA M, Brana I, Bono P, Postel-Vinay S, et al
    First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
    Br J Cancer. 2020;123:1730-1736.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: